© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ranolazine stands out as a medication most pharmacists and chemists recognize for its use in treating chronic angina. Beyond its clinical footprint, the material brings a range of chemical properties to the table. Its chemical formula is C24H33N3O4, and the molecular weight sits at about 427.54 g/mol. In my experience handling pharmaceutical substances, the physical form of Ranolazine often reveals flakes or crystalline powder, usually white to off-white. Ranolazine does not show strong odor, which already signals handling comfort compared to more volatile or aromatic compounds. When stored at room temperature, it remains stable, which adds a layer of reassurance for labs focused on consistent results and safety.
Looking at Ranolazine under standard laboratory conditions, the solid structure gives it a significant density, calculated at roughly 1.18 g/cm³. It does not dissolve well in water, but organic solvents such as ethanol or dimethyl sulfoxide will usually do the trick in preparing workable solutions. Its melting point, measured in the range of 118 to 122°C, enables precise handling during processing, especially during recrystallization or quality assurance checks. The molecular structure involves a piperazine moiety fused to a benzyl group, contributing to its unique chemical behavior. For safety and effectiveness, every technician needs to recognize both the melting point and the solubility profile before preparing any mixture or formulation.
Ranolazine counts as a raw material in pharmaceutical and chemical syntheses, so knowing its hazardous properties matters. Some materials in this class release dust during handling, and it's clear to anyone who’s worked the bench that powders bring risk for inhalation or accidental spillage. Material safety data notes that while Ranolazine causes some irritation to eyes and skin, it does not show acute toxicity at levels typical of ordinary laboratory or hospital work. Handling requires gloves and dust masks, and careful attention to good manufacturing and laboratory practices. Waste should always be disposed of in chemical-safe containers, and the workspace needs daily cleaning to prevent build-up of residues. Hazard statements flag it as non-flammable, but basic storage habits—dry, out of direct sunlight, away from acids or alkalis—extend shelf life and support workplace safety.
Commercial forms of Ranolazine usually arrive as flakes, crystalline solid, fine powders, or pearls, depending on the supplier's finishing step. Pharmacies and manufacturers rely on certified specifications: purity (above 98%), identified by HPLC methods, loss on drying (no more than 0.5%), and traces of related substances or heavy metals kept within extremely low limits. Some suppliers provide Ranolazine pre-dissolved in ethanol or as stable solutions, catering to custom research or pilot manufacturing needs. Considering density and the flake or powder form, precise weighing becomes essential—tiny overages shift dosages, especially at scale. Laboratories usually adopt semi-automated or closed weighing stations to cut down airborne powder exposure, a practice that keeps both product and personnel safe.
Ranolazine’s HS Code, 2934999099, links it under the broader regulatory umbrella for organic compounds with nitrogen functionality. Import-export authorities rely on this code to track shipments and enforce customs standards, a fact anyone handling cross-border logistics comes to appreciate. For those developing or exporting raw materials, registration requires supporting documentation about origin, purity, and intended use. On the regulatory side, both the FDA and EMA check for validated sources and proper labeling, and finished products need full traceability from these raw material lots. European and North American guidelines push for full documentation, stability testing, and batch-level certification. The need for these steps feels heavy, but in practice, these layers protect both end users and organizations from accidental contamination or regulatory pushback.
Production of Ranolazine brings up the question of environmental handling as more manufacturers look to cleaner, leaner processes. Green chemistry strategies make a difference here—solvent recycling, reducing solvent volume, or switching to safer alternatives drop both costs and environmental impact. From my experience, implementing closed-loop solvent systems not only reduces chemical waste, but also brings workplace emissions under tighter control. Some companies pursue biodegradable packaging and strive for ISO-certification in their supply chains. A team culture that empowers feedback from every worker—chemist, shipper, or janitor—means that failures in material handling procedures get caught fast, turning potential hazards into learning opportunities. Training, PPE audits, and annual refresher courses back up these improvements, embedding safety into everyday routines.
Using Ranolazine in research or production always means staying updated on changing protocols and legal rules. I often see teams prioritizing lot consistency, clear labeling, and digital batch records. This careful approach simplifies recalls, eases audits, and gives every user confidence in the material quality. Feedback loops between operators and suppliers create space for incremental changes—smaller packages, better labeling, updated certificates of analysis—so waste drops and compliance gets easier. In short, progressing in handling and regulatory management of Ranolazine means a focus on hands-on skills, constant information updates, and direct communication, all of which help to build a resilient and safe framework for everyone working with, transporting, or consuming this chemical.
